Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Jan 29, 2026
Reporting period
Not applicable
Filed with the SEC
Feb 2, 2026
CEOTax withholding
Context
Classification
tax withholding
Code F — shares delivered to pay exercise price or tax liability
Planned / mechanical clue
Tax mechanics (code F)
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001093557-26-000013
Filed / recorded
Feb 2, 2026, 9:46 PM UTC
Added to OQRO
Oct 2, 2026, 12:27 PM UTC
Parser
form4-xml-v1
Data quality
Verified: identifiers matched exactly
Issuer
DEXCOM INC
Issuer CIK
1093557
Ticker
DXCM
Reporting person
Jacob Steven Leach
Relationship
Director, Officer
Officer title
President, CEO, and Director
Security
Common Stock
Table
Non-derivative (Table I)
Transaction date
Jan 29, 2026
Transaction code
F
Shares / units
3,058
Price per share
$73.36
Acquired / disposed
Disposed (D)
Shares owned after
337,051
Ownership form
Direct
Amendment
No
Footnotes from the filing
Represents the number of shares required to be withheld by the Issuer to cover tax withholding and remittance obligations in connection with the net settlement of PSUs and does not represent a sale by the Reporting Person.
Included in this number are 84,537 unvested restricted stock units, 35,906 of which were granted on March 8, 2025 and shall vest through March 8, 2028, 22,798 of which were granted on March 8, 2025 and shall vest through March 8, 2027, 17,368 of which were granted on March 8, 2024 and shall vest through March 8, 2027, 8,465 of which were granted on March 8, 2023 and shall vest through March 8, 2026, and 102 additional shares acquired under the Issuer's Amended and Restated 2015 Employee Stock Purchase Plan.
Congress trade